In the field of pharmaceutical research and development and innovation, transdermal formulations are gradually becoming the focus of market attention because of their unique delivery methods and excellent therapeutic effects. To ensure the safety and effectiveness of transdermal formulations, adhesion is one of the core indexes. CD Formulation specializes in adhesion testing for transdermal formulations and is dedicated to offering researchers comprehensive, accurate, and efficient testing services.
The adhesion of transdermal formulations is the guarantee of continuous supply of their efficacy. The patch must remain in full contact with the skin throughout the delivery process to ensure that it does not migrate or fall off during use, thus facilitating the absorption of the drug in the patch into the systemic circulation through the skin. If the adhesion ability is too strong, when the administration is stopped or the skin needs to be peeled off at the end of the administration, it may cause adverse reactions such as skin residual glue or skin damage, affecting the overall usability of the product.
We conduct several types of adhesion tests to evaluate various aspects of transdermal patch performance:
Fig.1 Transdermal formulation adhesion testing. (Eva Gutschke, et al. 2010)
1. Preparation
Choose the transdermal patches and any substrates or test surfaces. Place the transdermal patch on the surface with the adhesive side down. Press it down uniformly to ensure good contact and adhesion.
2. Adhesion Testing
Peel Test: Use a peel tester to apply a steady force to peel the patch away from the substrate at a specific angle (usually 180 degrees) and speed.
Shear Test: Apply a shear force parallel to the surface. This can be done using a shear tester or similar device.
Tack Test: Use a tack meter to press a probe into the adhesive and then pull it away.
3. Removal Testing
Remove the patch from the surface at a controlled speed.
4. Data Analysis
Compare the measured adhesion values against the specifications and standards for the formulation.
Fig.2 Flow chart of adhesion testing (CD Formulation)
Technology: Technology for Adhesion Testing
Journal: European Journal of Pharmaceutics and Biopharmaceutics
IF: 5.571
Published: 2010
Results: It was the aim of the study to evaluate the suitability of the probe tack test as a method of predicting the long-term adhesion properties of transdermal patches to human skin. Twelve different types of polyacrylate pressure sensitive adhesives have been characterized using the probe tack test. For the analysis of the obtained data a novel procedure was developed that is based on two parameters: the deformation compliance κ and the critical return speed vc. In addition to the in vitro characterization, the in vivo adhesive properties were investigated in a double-blinded and randomized wear study by eight volunteers for a period of 7 days of wear. The adherent area and the size of the dark ring were defined in a percentage of the patch area by analysing digital photographs. The in vitro data correlate mostly with the in vivo performance of the tested adhesives after 7 days. Accordingly, the probe tack test could be a helpful tool during the development of transdermal patches.
CD Formulation is at the cutting edge of adhesion testing for transdermal formulations, thanks to the combination of our highly skilled technical staff and advanced equipment. This unique advantage guarantees that your transdermal patches will be effective and adhere to high-quality standards. For any of your research and development needs, please do not hesitate to contact us, and our team will respond within three working days.
References